The way in which data on the prescribing of drugs by doctors in Northern Ireland has been collected and analysed with the aid of electronic data processing equipment which was first installed in 1966 has been described by Wade and Hood (1972 (Editorial, 1952) . Later, after the establishment of a Registry of Blood Dyscrasias, there was further confirmation that chloramphenicol could occasionally cause marrow damage and this hazard was widely discussed in the world literature (Wade, 1970) .
EARLY STUDIES IN NORTHERN IRELAND
The prescribing of chloramphenicol by general practitioners in Northern Ireland was first examined in December 1962 (Wade, 1966 (Engels and Siderius, 1968) .
AMPHETAMINES
Benzedrine was first prepared in 1887 (Edeleano, 1887) and was introduced to clinical medicine in the early 1930s, first as an inhalant to reduce nasal congestion and then for the treatment of narcolepsy (Prinzmetal and Bloomberg, 1935) . During the war amphetamines were used in the armed Forces as an antidote to fatigue (Cuthbertson and Knox, 1947) and later became widely used in the treatment of depression and obesity.
The first observation of addiction to amphetamines was reported by Waud (1938) , and after the war there were reports of psychotic states occurring in patients addicted to them (Norman and Shea, 1945; Knapp, 1952) . Masaki (1956) reported the serious situation which had arisen in Japan where he estimated that at least 500,000 persons, mainly between the ages of 16 and 30, were misusing amphetamines. The Japanese Pharmacists' Association believed his estimate to be far too small and claimed that 1,500,000 people were misusing the drugs. In Sweden there was also a serious problem of amphetamine addiction; it was estimated that in a total population of 7,000,000 persons there were 7,000 amphetamine addicts. In Australia, Bell and Trethowan (1961) informing them that the characteristic and easily recognizable purple heart shaped tablet was being withdrawn and that in future Drinamyl would be marketed as a blue tablet. Despite this, leaders in the Lancet (1964 and still acquiesced with the view expressed by the Ministry of Health Interdepartmental Committee on Drug Addiction (1961) that amphetamine addiction was not a serious problem, although Gibson and Wade (1964) were of the opinion that at that time Drinamyl misuse represented the most serious drug addiction problem in the United Kingdom, and the United Nations Commission on Narcotic Drugs (1965) had recommended all member States to take steps to control the misuse of amphetamines.
PRESCRIBING OF AMPHETAMINES IN NORTHERN IRELAND
The first investigation of the use of amphetamines by doctors in general practice in Northern
Ireland was reported by Moorehead (1968) . He found a three-fold increase in the sales of amphetamines by wholesalers to pharmacies between 1963 and 1966. This was in sharp contrast to the hospital services of the Province where the prescribing of amphetamine had at this time become negligible. Hood and Wade (1968) made a detailed analysis of the prescribing of amphetamines over the threemonth period April-June 1966. In order to compare the use of the 11 preparations of amphetamine and of phenmetrazine which were being prescribed in Northern Ireland at that time, and which were of different doses and different composition, a 'unit' of amphetamine was defined as the equivalent of 5 mg of amphetamine (Table I ). In the three-month period of the survey, 11,400 prescriptions were written for almost a million units of amphetamine. There were great differences in the 444 practices the total prescribing of amphetamines in the Province. The prescribing of amphetamines was much greater in the east of the Province than in the west (Figure 2) , and in Belfast the number of units prescribed per 1,000 patients was 10 times more than in Co. Fermanagh (Table III) . There were three small towns on the east coast where more than 2,000 units per 1,000 patients were prescribed in the three-month period, and two areas in Co. Fermanagh where none at all was prescribed. After this survey the prescribing of amphetamines was kept under continuous monthly surveillance. Figure 3 shows BRONCHODILATOR AEROSOLS Sympathomimetic amines are effective bronchodilators, relieving the bronchospasm and dyspnoea of asthma, but when given systemically they often cause an increase in heart rate and palpitations which patients may find unpleasant. In 1959 pressurized aerosols of isoprenaline were marketed. These allowed the inhalation of small metered doses which usually gave effective relief of bronchospasm and did not affect the heart rate. Pressurized aerosol preparations are convenient, effective, and DISTRIBUTION It was in that year that Beryl Corner reported to a meeting of chest physicians her observation that there had been an increase in the Bristol area of deaths of children from asthma (Smith, 1966) . Speizer, Doll, and Heaf (1968) examined the data of the Registrar General and confirmed that in England and Wales there had been a considerable increase in deaths from asthma between 1960 and 1965. It was especially marked in young persons aged 10-14 and in many instances the circumstances of death strongly suggested that the patient had taken an overdose of bronchodilator aerosols. As a result of these investigations the Committee on Safety of Drugs issued a statement in June 1967 to all doctors advising that patients be warned of the dangers of excessive use of pressurized aerosols. At the same time manufacturers began to print a warning against excess use on all containers and the Poisons Board limited the sale of these aerosols so that they could be obtained only by a doctor's prescription. The institution of these measures was followed over the next two years by a fall in the mortality due to asthma to its pre-1960 level. Inman and Adelstein (1969) estimated that between 1961 and 1967 3,500 more deaths from asthma occurred than had occurred in the previous seven years.
The hazards of the use of aerosols containing sympathomimetic amines were widely discussed in both the medical and the lay press after the statement by the Committee on Safety of Drugs was issued, but the mechanism by which the increase in mortality came about is still the subject of controversy.
It was assumed that the sudden deaths were due to the action of the J-adrenergic stimulant drugs on the heart, and for this reason orciprenaline (Alupent) and salbutamol (Ventolin), drugs which have less action on the 3-adrenergic receptors of heart muscle than adrenaline or isoprenaline, were welcomed when they became available in 1968 and 1969, respectively. The data processing equipment became available in Northern Ireland just at the time when these hazards of the bronchodilator aerosols were being recognized, and the prescribing of the pressurized aerosols has been monitored since Figure 4 ) the number of different preparations available increased and in October 1971, 7,351 prescriptions for 12 preparations were written. More than half these prescriptions, however, were either for the sympatheticomimetic amines orciprenaline (Alupent) and salbutamol (Ventolin), which were believed to be safer than isoprenaline, or for disodium cromoglycate (Intal) which was introduced in 1968; this is not a sympatheticomimetic drug and is believed to act by interfering with the release ofhistamine or histaminelike substances when allergic reactions occur. The promotion of all these three preparations has stressed their freedom from cardiac toxicity.
Although in 1970 the total number of prescriptions had almost doubled compared with 1966, the prescribing of aerosols containing isoprenaline or adrenaline was less than it was in 1966.
DISCUsSION
The first investigation of the prescribing of chloramphenicol in Northern Ireland was made in 1962, 13 years after the introduction of the drug and 11 years after the first reports of its hazards which were widely discussed in the intervening years in the world's medical journals. It is unfortunate that there are no data available for the prescribing of chloramphenicol in the early 1950s. It is reasonable to presume that the highest level of prescribing occurred in those years and that by 1962 it had already fallen very considerably. It was a surprise to find in 1962 that it was still so widely used and its continued and seemingly unjustified wide use led the Dunlop Committee to issue its warning in 1967. Even that warning reduced the use by only half. These findings and the evidence that heavy prescribing was confined to a very few doctors suggest that even though there is wide publicity in medical journals about the adverse reactions of a drug, the prescribing habits of some doctors do not change, and even the warnings of the Dunlop Committee do not reach or do not carry weight with some practitioners.
The slow response of doctors in general practice to reports of adverse reactions of amphetamines was shown by Moorehead (1968) . Between 1963 and 1966 he found a great increase in the prescribing of amphetamines at a time when there was much concern expressed in both the medical and the lay press about the misuse of the drugs and when hospital doctors had almost ceased to prescribe It is interesting to see the very rapid reduction in the excess death rate from asthma which was attributed to the use of pressurized aerosols of sympatheticomimetic drugs. This suggests that the warnings about the very serious hazard of sudden death due to misuse of aerosols were successfully conveyed to both patients and doctors. Yet, despite this, the prescribing of aerosols containing isoprenaline and adrenaline decreased only slightly over the five-year period 1966-70. Over this time there was a great increase in the overall number of aerosol preparations prescribed. But this increase appears to have been mainly of orciprenaline (Alupent), salbutamol (Ventolin), and disodium cromoglycate (Intal) , all of which are thought to be less hazardous than isoprenaline. In this instance the rapid change in the pattern of prescribing may be due not only to appreciation by doctors of the hazards of isoprenaline but also to the appearance of new and apparently safer drugs on the market and their vigorous presentation by their manufacturers.
No doubt some general practitioners keep a close watch on contemporary information on drugs and their adverse reactions and change their prescribing habits appropriately. But it would seem from these studies that the prescribing habits of most doctors are firmly fixed and that changes in their habits occur slowly and only after a long time lag. There are some doctors whose response seems to be very slow. This would suggest that considerable weight should be given in postgraduate teaching to the discipline of clinical pharmacology and more thought should be applied to the dissemination of unbiased information about drugs. Perhaps the torrent of drug promotional literature is a factor in diverting the attention of doctors from more important information about drugs which they require if their patients are to be treated as effectively and safely as possible.
SUMMARY
The prescribing by general practitioners of chloramphenicol, the amphetamines, and the pressurized aerosols of bronchodilator drugs has been studied in Northern Ireland. All these preparations have been associated with serious adverse reactions, aplastic anaemia, addiction, and sudden death. Even so the prescribing of these drugs by doctors changed only slowly over the years of investigation and the studies suggest that more thought is needed on the dissemination of unbiased information about drugs.
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